Pulmonx Corporation
LUNG$87M
Micro CapNASDAQSurgical & Medical Instruments & Apparatus🇺🇸North AmericaREDWOOD CITY291 employees
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
LUNG News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
No drugs found in this phase.
📑
→Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
Catalyst Verdict
Full breakdown — the signals behind the verdict
Market-Implied Move
Regulatory Approvals
Frequently asked questions
When is Pulmonx Corporation's next FDA catalyst?→
Pulmonx Corporation's (LUNG) next tracked catalyst is a Earnings expected November 11, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track LUNG biotech catalysts?→
Add LUNG to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Pulmonx Corporation's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply